These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 233896)

  • 21. Alanine point-mutations in the reactive region of bovine pancreatic trypsin inhibitor: effects on the kinetics and thermodynamics of binding to beta-trypsin and alpha-chymotrypsin.
    Castro MJ; Anderson S
    Biochemistry; 1996 Sep; 35(35):11435-46. PubMed ID: 8784199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interaction of proflavin with deoxytetraribonucleoside triphosphate 5'-d(ApGpCpT): thermodynamic analysis from (1)H NMR data].
    Veselkov AN; Davis D; Dymant LN; Parkes H; Shipp D
    Biofizika; 1992; 37(5):851-8. PubMed ID: 1335287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On the changes in alpha-chymotrypsin stability after its modification by polyelectrolytes].
    Bessmertnaia LIa; Kozlov LV; Antonov VK
    Biokhimiia; 1977 Oct; 42(10):1825-34. PubMed ID: 922069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Competitive cooperative bindings of a small ligand to a linear polymer. II. Investigations on the mechanisms of proflavine binding to poly (A) and DNA.
    Dourlent M; Hogrel JF
    Biopolymers; 1976 Jan; 15(1):29-41. PubMed ID: 1244903
    [No Abstract]   [Full Text] [Related]  

  • 25. [NMR study of complex formation of aromatic ligands with heptadeoxynucleotide 5'-d(GCGAAGC) forming stable hairpin structure in aqueous solution].
    Veselkov AN; Eaton RJ; Semanin AV; Pakhomov VI; Dymant LN; Karavaev L; Davies DV
    Mol Biol (Mosk); 2002; 36(5):880-90. PubMed ID: 12391853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of the soybean Bowman-Birk proteinase inhibitor and of its chymotrypsin and trypsin inhibiting fragments to bovine alpha-chymotrypsin and bovine beta-trypsin. A thermodynamic study.
    Ascenzi P; Amiconi G; Bolognesi M; Menegatti E; Guarneri M
    J Mol Recognit; 1990; 3(5-6):192-6. PubMed ID: 2096886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solution structure and thermodynamics of 2',5' RNA intercalation.
    Horowitz ED; Lilavivat S; Holladay BW; Germann MW; Hud NV
    J Am Chem Soc; 2009 Apr; 131(16):5831-8. PubMed ID: 19309071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protonation linked equilibria and apparent affinity constants: the thermodynamic profile of the alpha-chymotrypsin-proflavin interaction.
    Bruylants G; Wintjens R; Looze Y; Redfield C; Bartik K
    Eur Biophys J; 2007 Dec; 37(1):11-8. PubMed ID: 17443320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Features of binding of proflavine to DNA at different DNA-ligand concentration ratios].
    Berezniak EG; gladkovskaia NA; Khrebtova AS; Dukhopel'nikov EV; Zinchenko AV
    Biofizika; 2009; 54(5):805-12. PubMed ID: 19894617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A biochemical logic gate using an enzyme and its inhibitor. Part II: The logic gate.
    Sivan S; Tuchman S; Lotan N
    Biosystems; 2003 Jun; 70(1):21-33. PubMed ID: 12753934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A general method of analysis of ligand binding to competing macromolecules using the spectroscopic signal originating from a reference macromolecule. Application to Escherichia coli replicative helicase DnaB protein nucleic acid interactions.
    Jezewska MJ; Bujalowski W
    Biochemistry; 1996 Feb; 35(7):2117-28. PubMed ID: 8652554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thermal pertubation techniques in characterizing ligand-macromolecule interactions: Theory and application to the proflavins-alpha-chymotrypsin system.
    Sturgill TW; Johnson RE; Biltonen RL
    Biopolymers; 1978 Jul; 17(7):1773-92. PubMed ID: 233896
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.